Based on that, his team developed an anti-Tn-MUC1 CAR-T cell that recognized the cancer-specific cell surface expressing Tn-MUC1, and demonstrated the target-specific cytotoxicity and suppression of tumor growth in xenograft models of T cell leukemia and pancreatic cancer (81). This evidence concerns the gene MUC1 and pancreatic neoplasm.